Teradyne AI Stock Analysis
Teradyne (TEY) AI Stock Analysis
Teradyne
(XETRA:TEY)
No summary available
Teradyne (TEY) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 41.49B
- Dividend Yield
- 0.18%
- Average Volume (3M)
- 564
- Price to Earnings (P/E)
- 30.3
- Beta (1Y)
- 0.52
- Revenue Growth
- 66.23%
- EPS Growth
- 201.88%
- Country
- Germany
- Employees
- 6,600
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Semiconductors
Teradyne Business Overview & Revenue Model
Company Description
Teradyne, Inc., established in 1960 and headquartered in North Reading, Massachusetts, is a global leader specializing in the creation, production, sale, and maintenance of automated testing solutions. The company's operations are categorized into fo...
Teradyne Earnings Call Summary
The call was strongly positive, with record revenue and EPS, broad AI-driven growth across all business groups, record memory and robotics results, strong cash flow, expanding backlog and positive 2027 expectations. The main challenges were mobile remaining below historical levels, quarterly and compute-program timing variability, near-term robotics visibility, CPO ramp uncertainty, supply-chain lead times and product-mix and inflationary pressure on margins. Highlights significantly outweighed lowlights.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For the fourth quarter, Teradyne expects revenue in the range of $1.25 billion to $1.35 billion, non GAAP EPS of $1.95 to $2.25, gross margins in the range of 57.5% to 58.5%, operating expenses at 28.5% to 29.5% of fourth quarter sales, and a non GAAP operating profit rate between 28-30%; the Q4 guidance midpoint of $1.3 billion represents growth of approximately 20% over the last year's fourth quarter, bringing full year revenue to approximately $5.2 billion, up over 60%. Q4 is expected to be the fourth consecutive quarter of revenue above $1.25 billion, memory is expected to continue at a really strong level, and 2027 is expected to be another year of healthy growth, with each quarter next year expected to grow in comparative to 26, although there could be variability within quarter. CPO test equipment TAM is estimated at somewhere in the neighborhood of $100 million in 2026 and could grow to $300 million to $700 million by 2028.
Teradyne Risk Analysis
Teradyne disclosed 34 risk factors in its most recent earnings report. Teradyne reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksTeradyne Peers Comparison
Overall Rating
FORM72Outperform
ONTO69Neutral
CAMT64Neutral
COHU62Neutral
AEHR57Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 72Outperform | $6.71B | 43.14 | 15.83% | ― | 29.08% | 320.89% | |
| 69Neutral | $9.69B | 70.05 | 7.44% | ― | 30.86% | -13.97% | |
| 64Neutral | $4.77B | 37.17 | 19.34% | ― | 12.18% | 173.28% | |
| 62Neutral | $2.06B | -95.11 | -2.90% | ― | 34.00% | 69.09% | |
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
| 57Neutral | $1.95B | 1103.69 | 1.20% | ― | -15.21% | -81.50% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:TEY | Teradyne | 243.90 | 96.77 | 65.77% | |
| AEHR | Aehr Test | 65.78 | 45.04 | 217.16% | |
| CAMT | Camtek | 107.05 | 7.48 | 7.51% | |
| COHU | Cohu Inc | 45.98 | 23.57 | 105.15% | |
| FORM | Formfactor | 95.78 | 45.06 | 88.84% | |
| ONTO | Onto Innovation | 215.06 | 85.33 | 65.78% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
